<?xml version="1.0" encoding="UTF-8"?>
<p>The primary efficacy endpoint was the duration of severe neutropenia (DSN) in Cycle 1, with severe neutropenia defined as ANC &lt;0.5 × 10
 <sup>9</sup>/L (grade 4 per NCI CTCAE) and DSN defined as the interval from the day of first observation of grade 4 neutropenia to first ANC recovery to ≥2.0 × 10
 <sup>9</sup>/L.
</p>
